APA

Aapro M. S., Cameron D. A., Pettengell R., Bohlius J., Crawford J., Ellis M., Kearney N., Lyman G. H., Tjan-Heijnen V. C., Walewski J., Weber D. C. & Zielinski C. (20061218). EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. : European journal of cancer (Oxford, England : 1990).

Chicago

Aapro M S, Cameron D A, Pettengell R, Bohlius J, Crawford J, Ellis M, Kearney N, Lyman G H, Tjan-Heijnen V C, Walewski J, Weber D C and Zielinski C. 20061218. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. : European journal of cancer (Oxford, England : 1990).

Harvard

Aapro M. S., Cameron D. A., Pettengell R., Bohlius J., Crawford J., Ellis M., Kearney N., Lyman G. H., Tjan-Heijnen V. C., Walewski J., Weber D. C. and Zielinski C. (20061218). EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. : European journal of cancer (Oxford, England : 1990).

MLA

Aapro M S, Cameron D A, Pettengell R, Bohlius J, Crawford J, Ellis M, Kearney N, Lyman G H, Tjan-Heijnen V C, Walewski J, Weber D C and Zielinski C. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. : European journal of cancer (Oxford, England : 1990). 20061218.